DawMed Systems PLC
17 March 2008
17 March 2008
DAWMED SYSTEMS PLC
('DawMed' or the 'Company')
MEMORANDUM OF UNDERSTANDING
The Board of DawMed, the AIM listed medical device company which designs,
manufactures, sells and services healthcare decontamination equipment and
associated consumables used by NHS Trust hospitals, private hospitals, clinics
and Primary Care practitioners, is pleased to announce the signing of a
Memorandum of Understanding between its operating subsidiary, DawMed
International Limited and Schulke & Mayr GmbH, based in Germany, which is a
major manufacturer and supplier of medical and industrial chemicals and gases
throughout Northern Europe with particular interest in healthcare markets.
Schulke & Mayr is the Germany based subsidiary of its long established ultimate
parent company AIR Liquide, a world leader in medical and industrial gases and
chemicals, based in France and having a corporate presence in 72 countries since
its formation in 1902,
The Memorandum of Understanding provides for DawMed International Limited
('DMI') to supply its 'AERclens Chemical' machine, a washer-disinfector ('WD')
for flexible endoscopes, to Schulke & Mayr.
Schulke & Mayr will resell, install and service the DawMed's AERclens WD
decontamination equipment initially in the healthcare markets of Germany and
Austria and will also sell all detergent and disinfectant chemicals directly to
the end users of that equipment.
This venture is the result of Dawmed's continuous implementation of its strategy
to increase its endeavours in export markets, particularly in, but not limited
to Europe and this Memorandum represents an important step forward for DawMed
and a not unimportant first for Schulke & Mayr.
Commenting, Executive Chairman, Kevin Gilmore, said: 'Today's announcement is a
further meaningful positive for DawMed which may or may not represent the first
stage of a potential distributorship agreement with Schulke & Mayr for sales of
DawMed's AERclens decontamination equipment in Northern Europe.'
Jean-Luc Charlet, Managing Director of Schulke & Mayr GmbH said 'We are
extremely pleased with this agreement with Dawmed. This cooperation will help
our customers to get a very efficient and very reliable solution to their daily
problems in the field of instrument disinfection'
Enquiries:
Kevin M Gilmore Tel: 01608 682244
Executive Chairman Mob: 07785 396666
Beaumont Cornish Limited
Roland Cornish Tel: 020 7628 3396
Bishopsgate Communications Limited
Dominic Barretto Tel: 020 7562 3350
For further information about the Company's business please visit www.dawmed.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.